Movement Disorders Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Department of Neurology

Deep brain stimulation

Deep brain stimulation (DBS) is an emerging treatment for primary dystonia that uses an implanted neurostimulator, a device similar to a pacemaker, to send mild electrical pulses to selected parts of the brain. The Food and Drug Administration has granted Boston Children’s approval to use DBS in children 7 and older with primary dystonia that has not responded to medications. Led by Scellig Stone, MD, PhD, at Boston Children’s, we will be tracking patients’ long-term outcomes as part of a hospital-approved treatment protocol.

Brain mechanisms of movement disorders

Research on movement disorders seeks to learn how the brain is altered to cause abnormal movements, how genetic mutations lead to these changes and what parts of the brain are involved. For example, we know of different genetic mutations that are associated with primary dystonia, but we don’t know how the mutations actually lead to dystonia, or what other genetic traits make the symptoms less or more severe. Together with Nutan Sharma, MD, PhD, at Massachusetts General Hospital, we are working to understand the cellular and molecular pathways that cause dystonia.

Brain imaging in pediatric dystonia

Jeff Waugh, MD, PhD, at Boston Children’s, is conducting research using advanced brain MRI imaging in children and young adults with dystonia. This research aims to determine what brain regions are malfunctioning and whether children with dystonia have differences in brain structure and function that explain their condition. (For enrollment information, contact

Dystonia genotype-phenotype correlations

This study, conducted in conjunction with Massachusetts General Hospital, is seeking genotypes (genetic makeups) and/or brain characteristics that give information to better predict, diagnose or treat dystonia. It is currently enrolling adults and teens who have a focal dystonia (such as cervical dystonia, a segmental dystonia, a multi-focal dystonia or a known dystonia gene mutation), as well as healthy adults. The study includes a physical exam, a blood draw and brain imaging.

In addition, this program has established a genetic and tissue bank to collect and store samples and information from people with dystonia for research purposes. Anyone 7 or older diagnosed with any type of dystonia can take part. For information about either study, contact: Trisha Multhaupt-Buell, MS, CGC,

Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337